Personalized Medicines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Personalized Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness

Segment by Application
Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Abbott
Agendia NV
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
Sanofi
23andMe